NCT03769961

Brief Summary

The proposed study aims to characterize ataxia occurring in essential tremor and essential tremor with DBS.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2018

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2018

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

December 6, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 10, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 14, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 14, 2020

Completed
Last Updated

September 17, 2020

Status Verified

September 1, 2020

Enrollment Period

1.8 years

First QC Date

December 6, 2018

Last Update Submit

September 15, 2020

Conditions

Keywords

essential tremordbs

Outcome Measures

Primary Outcomes (1)

  • Ataxia Differences between DBS and no DBS

    Compare the Scale of the Assessment and Rating of Ataxia (SARA) total score between DBS and no DBS participants with essential tremor. This 8-item scale rates gait (0-8 points), stance (0-6 points), sitting (0-4 points), speech disturbance (0-6 points), finger chase (0-4 points), nose-finger test (0-4 points), fast alternating hand movements (0-4 points), and heel-shin slide (0-4 points). Motor activists of the four extremities (items 5-8) assessments are performed bilaterally, mean values to obtain a total score. Cumulative score ranges from 0 (no ataxia) to 40 (most severe ataxia).

    Visit 2 (after DBS has been turned off for 3-10 days)

Secondary Outcomes (1)

  • Balance Confidence

    Visit 2 (after DBS has been turned off for 3-10 days)

Study Arms (4)

ET (DBS-, Ataxia+)

Essential Tremor without DBS with Ataxia on examination

Other: No intervention

ET (DBS-, Ataxia-)

Essential Tremor without DBS and without Ataxia on examination

Other: No intervention

ET (DBS+, Ataxia+)

Essential Tremor with DBS with Ataxia on examination

Other: No intervention

ET (DBS+, Ataxia-)

Essential Tremor with DBS without Ataxia

Other: No intervention

Interventions

No interventions - Observational study

ET (DBS+, Ataxia+)ET (DBS+, Ataxia-)ET (DBS-, Ataxia+)ET (DBS-, Ataxia-)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Essential Tremor participants with and without ataxia

You may qualify if:

  • Essential Tremor diagnosis at least 3 years duration
  • Absence of other neurological signes (such as dystonia, ataxia, or Parkinsonism)
  • Patients must be able to walk 2 minutes unassisted.
  • Patients must be able to understand and consent to be in the study.

You may not qualify if:

  • Patients who have had changes in DBS settings within the last 3 months.
  • Patients who have had no initial improvement or response to DBS.
  • ET medication changes in the last month.
  • Actively abusing alcohol.
  • A neurologic diagnosis other than ET that in the investigator's opinion could affect gait and/or balance.
  • Atypical tremor disorder including by not limited to tremor due to multiple sclerosis, medication-induced tremor, Parkinson's disease, or parkinsonian syndrome.
  • Dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Oregon Health & Science University

Portland, Oregon, 97201, United States

Location

VA Portland Health Care System

Portland, Oregon, 97239, United States

Location

Related Publications (4)

  • Ramirez-Zamora A, Boggs H, Pilitsis JG. Reduction in DBS frequency improves balance difficulties after thalamic DBS for essential tremor. J Neurol Sci. 2016 Aug 15;367:122-7. doi: 10.1016/j.jns.2016.06.001. Epub 2016 Jun 2.

    PMID: 27423573BACKGROUND
  • Nazzaro JM, Lyons KE, Pahwa R. Deep brain stimulation for essential tremor. Handb Clin Neurol. 2013;116:155-66. doi: 10.1016/B978-0-444-53497-2.00013-9.

  • Kronenbuerger M, Konczak J, Ziegler W, Buderath P, Frank B, Coenen VA, Kiening K, Reinacher P, Noth J, Timmann D. Balance and motor speech impairment in essential tremor. Cerebellum. 2009 Sep;8(3):389-98. doi: 10.1007/s12311-009-0111-y. Epub 2009 May 19.

  • Fasano A, Herzog J, Raethjen J, Rose FE, Muthuraman M, Volkmann J, Falk D, Elble R, Deuschl G. Gait ataxia in essential tremor is differentially modulated by thalamic stimulation. Brain. 2010 Dec;133(Pt 12):3635-48. doi: 10.1093/brain/awq267. Epub 2010 Oct 5.

MeSH Terms

Conditions

Essential TremorAtaxiaCerebellar Diseases

Condition Hierarchy (Ancestors)

Movement DisordersCentral Nervous System DiseasesNervous System DiseasesDyskinesiasNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBrain Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 6, 2018

First Posted

December 10, 2018

Study Start

December 1, 2018

Primary Completion

September 14, 2020

Study Completion

September 14, 2020

Last Updated

September 17, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will share

Post data entry and verification, data and specimens will be de-identified (no 18 HIPAA identifiers and age aggregated for those \> 89 years old) and transferred to the Neurological Disorder Repository (MIRB # 3129). This repository is maintained at the Portland VA Health Care System. Verification of the coded data set creation and the absence of the identifiers will be created and retained in the study files. The research coordinator will be responsible for the creation and verification process. The key to the code will be maintained by the study and will not be released to the repository. The recipient investigator must present the data use agreement, documentation of an Institutional Review Boar (IRB) approved protocol and Informed Conset Form (ICF) allowing the release of the identifiable specimens/data, or the release of coded specimens/data.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
Data will be available within 6 months of study completion.
Access Criteria
Data access requests will be reviewed by an external Independent Review Board. Requestors will be required to sign a data access agreement.
More information

Locations